Medtronic (MDT)
(Delayed Data from NYSE)
$81.74 USD
-0.53 (-0.64%)
Updated Aug 14, 2024 04:00 PM ET
After-Market: $81.71 -0.03 (-0.04%) 5:10 PM ET
4-Sell of 5 4
B Value C Growth C Momentum C VGM
Brokerage Reports
0 items in cart
Medtronic PLC [MDT]
Reports for Purchase
Showing records 401 - 420 ( 506 total )
Company: Medtronic PLC
Industry: Medical - Products
Company: Medtronic PLC
Industry: Medical - Products
No Major Surprises at Analyst Meeting; Maintain NEUTRAL
Provider: WEDBUSH SECURITIES INC.
Company: Medtronic PLC
Industry: Medical - Products
Ongoing Challenges Hurt the Quarter; Maintain NEUTRAL
Provider: WEDBUSH SECURITIES INC.
Company: Medtronic PLC
Industry: Medical - Products
Heart Rhythm Society Conference Takeaways
Provider: WEDBUSH SECURITIES INC.
Company: Medtronic PLC
Industry: Medical - Products
AFib Technology Update: Topera 3 Years Later
Provider: WEDBUSH SECURITIES INC.
Company: Medtronic PLC
Industry: Medical - Products
AFib Technology Update: Topera 3 Years Later
Provider: WEDBUSH SECURITIES INC.
Company: Medtronic PLC
Industry: Medical - Products
1Q Preview: Expecting a Seasonally Soft Quarter but Fundamentals Remain Intact
Provider: WEDBUSH SECURITIES INC.
Company: Medtronic PLC
Industry: Medical - Products
1Q Preview: Expecting a Seasonally Soft Quarter but Fundamentals Remain Intact
Provider: WEDBUSH SECURITIES INC.
Company: Medtronic PLC
Industry: Medical - Products
IN.PACT Meets Primary Endpoint, As Expected
Provider: WEDBUSH SECURITIES INC.
Company: Medtronic PLC
Industry: Medical - Products
ACC Weekend Recap: Raising MDT PT; STJ Remains Our Favorite Cardio Stock
Provider: WEDBUSH SECURITIES INC.
Company: Medtronic PLC
Industry: Medical - Products
Company: Medtronic PLC
Industry: Medical - Products
Company: Medtronic PLC
Industry: Medical - Products
F3Q14 Review: Generally In Line and Fairly Valued; Maintain NEUTRAL
Provider: WEDBUSH SECURITIES INC.
Company: Medtronic PLC
Industry: Medical - Products
F3Q14 Review: Generally In Line and Fairly Valued; Maintain NEUTRAL
Provider: WEDBUSH SECURITIES INC.
Company: Medtronic PLC
Industry: Medical - Products
IN.PACT DEEP Trial for Below-The-Knee Revascularization Fails to Meet Safety and Efficacy Endpoints
Provider: WEDBUSH SECURITIES INC.
Company: Medtronic PLC
Industry: Medical - Products
Company: Medtronic PLC
Industry: Medical - Products
IN.PACT DEEP Trial for Below-The-Knee Revascularization Fails to Meet Safety and Efficacy Endpoints
Provider: WEDBUSH SECURITIES INC.
Company: Medtronic PLC
Industry: Medical - Products
In-Line Quarter; Increase PT to $55, but Maintain NEUTRAL
Provider: WEDBUSH SECURITIES INC.
Company: Medtronic PLC
Industry: Medical - Products
Preliminary 30-day Extreme Risk CoreValve Data Suggest Pluses and Minuses
Provider: WEDBUSH SECURITIES INC.
Company: Medtronic PLC
Industry: Medical - Products
Medical Devices - Bill to Repeal Medical Device Tax Gains Increasing Attention
Provider: WEDBUSH SECURITIES INC.